During this week’s roundtable, Positioning came up over and again.
Angoor
Up first Anuj Agrawal from Bangalore, India, pitched Angoor, a product in a highly competitive market that needs a crisp Positioning.
TrueRev
Then Ali Rizvi from San Carlos, California, pitched TrueRev, also a product with some customer traction that needs to be positioned better.
You can listen to the recording of this roundtable here:
Lexington-based Valo Health is one of the pioneering players in the AI-drug discovery market. Set up in 2019 as part of Flagship Pioneering’s initiatives, Valo has had quite a roller coaster ride so far.
>>>Let’s be strategic about our time and resources in 2025.
If you are facing Velocity challenges, we should look closely at your Positioning.
The lowest hanging fruit in terms of what CAN be fixed in a B-to-B SaaS venture is Positioning.
Even in B-to-C, Positioning can be fixed.
Today’s 669th FREE online 1Mby1M Roundtable for Entrepreneurs is starting NOW, on Thursday, January 23, at 8 a.m. PST / 11 a.m. EST / 5 p.m. CET / 9:30 p.m. India IST. CLICK HERE to join. PASSWORD: startup All are welcome!
Today’s 669th FREE online 1Mby1M Roundtable for Entrepreneurs is starting in 30 minutes, on Thursday, January 23, at 8 a.m. PST / 11 a.m. EST / 5 p.m. CET / 9:30 p.m. India IST. CLICK HERE to join. PASSWORD: startup All are welcome!
Do you want to join an Accelerator to begin your startup journey in 2025?
Hundreds of thousands of entrepreneurs get rejected by accelerators every year.
Y Combinator rejects 98% of their applicants.
How is the 1Mby1M Accelerator different? Let’s take a look.
If you are starting a new venture, we highly recommend Bootstrapping with a Paycheck.
This approach allows you to learn and grow while maintaining financial stability.
But you have to be deliberate about it.
In 2025, make the leap. Get started.
To accelerate your path to building a viable business, use our 1Mby1M Basic Program.
The high growth AI-drug discovery market has attracted several players. However, the high cost of drug development, and the slow regulatory process associated with drug release has also led to several consolidations. One such story is that of Berg Health.
>>>